Similar to what has been shown for other ECM‐reducing strategies (Provenzano et al, 2012; Kirtane et al, 2017), TNFα‐CSG enhanced tumour perfusion and uptake of MRI contrast agents, indicating potential use for cancer imaging. This evidence concerns the gene TNF and cancer.